文献速递胸部CT

基于CT定量评估在定义进行性肺纤维化中的效用

Usefulness of CT Quantification-Based Assessment in Defining Progressive Pulmonary Fibrosis.
PubMed 文献 · Acad Radiol · 2024-06-13

回顾性纳入97例结缔组织病相关间质性肺病(CTD-ILD)患者,以总生存期最高区分度确定影像学进展的CT定量阈值为4%。该阈值定义进行性肺纤维化(PPF)与视觉评估一致率97.9%(95/97),且基于该阈值的PPF是总生存期不良的独立危险因素(HR 6.72,P=0.009)。

要点

  • CT定量影像学进展阈值为4%,与视觉评估定义PPF一致率97.9%(95/97)。
  • 定量阈值定义PPF是总生存期不良独立危险因素(HR 6.72,P=0.009)。
  • 视觉评估定义PPF(HR 8.86,P=0.002)和呼吸症状恶化(HR 12.73,P<0.001)亦为独立危险因素。

核心结论

  • CT定量影像学进展阈值4%在定义PPF方面可行,与视觉评估分组一致且具有预后性能。

研究设计与样本

  • 回顾性评估2007年4月至2022年10月诊断的CTD-ILD患者97例,中位随访30.3个月(范围4.7-198.1个月)。
  • 使用商业软件进行CT定量,求和磨玻璃影、实变、网状影和蜂窝影百分比。
  • 由两名胸部放射科医师独立评估视觉影像学进展,以高级放射科医师评估为最终结果。
  • 采用Cox回归基于视觉评估和定量阈值评估PPF预后。

诊断标准与关键数值

  • 影像学进展最佳定量CT阈值为4%,基于总生存期最高区分度确定。
  • 使用4%阈值诊断PPF 12例,视觉评估诊断PPF 14例,一致率97.9%(95/97)。
  • 呼吸症状恶化HR 12.73(P<0.001),视觉评估PPF HR 8.86(P=0.002),定量阈值PPF HR 6.72(P=0.009),均为总生存期不良独立危险因素。

临床应用与阅片要点

  • CT定量阈值4%可用于定义CTD-ILD患者的影像学进展性肺纤维化,与视觉评估一致性高。
  • 定量阈值定义的PPF与视觉评估定义的PPF均与总生存期不良独立相关。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

RATIONALE AND OBJECTIVES: To establish a quantitative CT threshold for radiological disease progression of progressive pulmonary fibrosis (PPF) and evaluate its feasibility in patients with connective tissue disease-related interstitial lung disease (CTD-ILD).

MATERIALS AND METHODS: Between April 2007 and October 2022, patients diagnosed with CTD-ILD retrospectively evaluated. CT quantification was conducted using a commercial software by summing the percentages of ground-glass opacity, consolidation, reticular opacity, and honeycombing. The quantitative threshold for radiological progression was determined based on the highest discrimination on overall survival (OS). Two thoracic radiologists independently evaluated visual radiological progression, and the senior radiologist's assessment was used as the final result. Cox regression was used to assess prognosis of PPF based on the visual assessment and quantitative threshold.

RESULTS: 97 patients were included and followed up for a median of 30.3 months (range, 4.7-198.1 months). For defining radiological disease progression, the optimal quantitative CT threshold was 4%. Using this threshold, 12 patients were diagnosed with PPF, while 14 patients were diagnosed with PPF based on the visual assessment, with an agreement rate of 97.9% (95/97). Worsening respiratory symptoms (hazard ratio [HR], 12.73; P < .001), PPF based on the visual assessment (HR, 8.86; P = .002) and based on the quantitative threshold (HR, 6.72; P = .009) were independent risk factors for poor OS.

CONCLUSION: The quantitative CT threshold for radiological disease progression (4%) was feasible in defining PPF in terms of its agreement with PPF grouping and prognostic performance when compared to visual assessment.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. Ahn Y, Kim HC, Lee JK, et al. Usefulness of CT Quantification-Based Assessment in Defining Progressive Pulmonary Fibrosis. Acad Radiol. 2024. PMID: 38876844. doi:10.1016/j.acra.2024.05.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。